DRKS00031139RecruitingNot Applicable
Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosis - GRAMS
MPI-NAT0 sites1,000 target enrollmentStarted: January 26, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 1,000
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 16 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Diagnosis Multiple Sclerosis or other demyelinating diseases of the CNS
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Not Applicable
Exploratory analysis of biomarkers predicting the treatment response and the prognosis in patients with gastric carcinomaGastric cancerJPRN-UMIN000036886Sapporo Medical University350
Recruiting
Not Applicable
Exploratory analysis of biomarkers predicting the treatment response and the prognosis in patients with esophageal carcinomaEsophageal cancerJPRN-UMIN000036884Department of Medical Oncology, Sapporo Medical University School of Medicine250
Recruiting
Not Applicable
Exploratory analysis of biomarkers predicting the treatment response and the prognosis in patients with colorectal carcinomaColorectal cancer Colon cancer Rectal cancerJPRN-UMIN000036891Department of Medical Oncology, Sapporo Medical University School of Medicine350
Recruiting
Not Applicable
Exploratory analysis of biomarkers predicting the treatment response in esophageal squamous cell carcinoma by using biopsy samplesEsophageal cancerJPRN-UMIN000008865Department of Therapeutic Oncology, Kyoto University Graduate School of Medicine100
Recruiting
Not Applicable
An exploratory investigation of the biomarker for senescence and arteriosclerosis in renal transplant donors and recipients.Recipients and donors in living-kidney transplantationJPRN-UMIN000004905Kagawa University, Faculty of Medicine45
